NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

GRAL

GRAIL Inc

May 09 • 01:44PM ET

35.92

Dollar change -0.18
Percentage change -0.50	%

Healthcare • Diagnostics & Research • USA • NASD

Peers: ILMN EXAS GH PACB TXG QGEN CRSP EDIT CDNA FULC

| Held by: XBI VTI VXF IBB IWR VHT IWD LABU IWS ITOT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-64.76	Insider Own	17.92%	Shs Outstand	33.89M	Perf Week	0.41%
Market Cap	1.27B	Forward P/E	-	EPS next Y	-13.19	Insider Trans	-3.44%	Shs Float	28.97M	Perf Month	44.26%
Income	-2027.01M	PEG	-	EPS next Q	-3.99	Inst Own	77.16%	Short Float	18.58%	Perf Quarter	11.52%
Sales	125.59M	P/S	10.10	EPS this Y	75.83%	Inst Trans	25.46%	Short Ratio	3.54	Perf Half Y	158.23%
Book/sh	73.86	P/B	0.49	EPS next Y	14.10%	ROA	-52.65%	Short Interest	5.38M	Perf Year	-
Cash/sh	21.63	P/C	1.66	EPS next 5Y	45.28%	ROE	-65.92%	52W Range	12.33 - 63.99	Perf YTD	101.23%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-89.93%	ROI	-79.23%	52W High	-43.87%	Beta	-
Dividend TTM	-	Quick Ratio	10.42	Sales past 5Y	127.56%	Gross Margin	-62.12%	52W Low	191.32%	ATR (14)	3.33
Dividend Ex-Date	-	Current Ratio	10.66	EPS Y/Y TTM	-37.19%	Oper. Margin	-597.09%	RSI (14)	58.34	Volatility	9.82% 10.16%
Employees	1000	Debt/Eq	0.03	Sales Y/Y TTM	34.90%	Profit Margin	-1613.92%	Recom	2.50	Target Price	26.00
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	52.58%	Payout	-	Rel Volume	0.42	Prev Close	36.10
Sales Surprise	11.20%	EPS Surprise	41.89%	Sales Q/Q	26.14%	Earnings	May 13 AMC	Avg Volume	1.52M	Price	35.92
SMA20	11.91%	SMA50	18.10%	SMA200	61.60%	Trades		Volume	430,524	Change	-0.50%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-21-25	Initiated	Canaccord Genuity	Buy	$32
Nov-27-24	Initiated	Morgan Stanley	Equal-Weight	$16
Nov-15-24	Initiated	Wolfe Research	Peer Perform
Oct-17-24	Initiated	Guggenheim	Neutral

May-02-25 12:52PM	Exact Sciences Q1 Earnings: Decent Quarter, But Growth Story Not Compelling (Seeking Alpha) +10.11%
Apr-30-25 05:43AM	Why GRAIL, Inc. (GRAL) is Surging in 2025 (Insider Monkey) -6.28%
Apr-29-25 04:01PM	GRAIL to Announce First Quarter 2025 Financial Results (PR Newswire)
Apr-22-25 04:01PM	GRAIL to Present New Data on Galleri and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting (PR Newswire) +12.38% +13.71%
Apr-21-25 04:47PM	This Cancer Test Could Become Routineand a Big Seller, Says Analyst (Barrons.com)
03:02PM	Loading…
Apr-16-25 03:02PM	GRAIL, Inc. (GRAL): A Bull Case Theory (Insider Monkey)
Apr-12-25 09:32AM	GRAIL's Galleri Progresses While Back In Accumulation Levels (Seeking Alpha)
Apr-08-25 09:49AM	How Does GRAIL Benefit From The Proposed MCED Legislation? (Seeking Alpha) -10.78%
Mar-31-25 11:36AM	Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses - Great Science, Risky Bet! (Insider Monkey) -5.16%
Mar-03-25 12:30PM	Is GRAIL, Inc. (GRAL) Among Jeff Bezos Investments in 2025? (Insider Monkey) -5.78%
Feb-26-25 04:05PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire) -10.45%
Feb-25-25 09:00AM	GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing (PR Newswire)
Feb-24-25 02:02PM	GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025 (Insider Monkey) +11.22%
Feb-21-25 10:00AM	Why Grail (GRAL) Is Falling Today (Insider Monkey) -14.72%
09:00AM	GRAIL to Present at TD Cowen 45th Annual Health Care Conference (PR Newswire)
02:15AM	Loading…
02:15AM	GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ... (GuruFocus.com)
Feb-20-25 04:02PM	GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results (PR Newswire) -9.20%
Feb-19-25 10:10AM	Investors Eye Biotech Sector as Cancer Therapy Market Surges (PR Newswire) +11.61%
Feb-12-25 04:02PM	GRAIL to Announce Fourth Quarter 2024 Financial Results (PR Newswire) +18.43% +33.93%
12:50PM	Why Grail (GRAL) Stock Is Jumping Today (Insider Monkey)
09:00AM	GRAIL and Quest Diagnostics Provide GRAIL's Galleri Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System (PR Newswire)
Jan-26-25 11:12PM	Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week (Investopedia)
Jan-23-25 12:42PM	Why Grail (GRAL) Is Rallying for a Second Straight Day (Insider Monkey) +14.71%
Jan-22-25 12:21PM	Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20% (Investopedia) +22.44%
Jan-21-25 10:48AM	Stock Market Today: Dow Jones Up After These Trump Moves; Cathie Wood Loads Up On AI Stock (Live Coverage) (Investor's Business Daily) +6.14%
Jan-13-25 06:49PM	Patient Reported Outcomes for GRAIL's Galleri Multi-Cancer Early Detection Blood Test Published in Lancet Oncology (PR Newswire)
Dec-18-24 04:01PM	GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire) -23.41% -5.25%
Dec-16-24 01:43PM	What's Going On With Illumina Stock On Monday? (Benzinga)
Dec-10-24 02:52PM	One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's (Investor's Business Daily) -6.03%
Dec-05-24 01:40PM	Stock Market Today: Dow Jones Keeps Losses Tidy As New Medical IPO Breaks Out (Live Coverage) (Investor's Business Daily) +10.78%
04:01PM	Loading…
Dec-03-24 04:01PM	GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-19-24 04:05PM	GRAIL to Participate in Upcoming Investor Conferences (PR Newswire) +5.64%
Nov-18-24 04:01PM	GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study (PR Newswire) -5.41%
09:16AM	Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? (Insider Monkey)
Nov-14-24 02:00PM	GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ... (GuruFocus.com)
Nov-12-24 04:06PM	GRAIL Reports Third Quarter 2024 Financial Results (PR Newswire) +5.50%
Nov-04-24 04:01PM	GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
Oct-29-24 04:01PM	GRAIL to Announce Third Quarter 2024 Financial Results (PR Newswire)
Oct-23-24 06:00PM	GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference (PR Newswire) -5.12%
Oct-21-24 04:01PM	GRAIL Appoints Sarah Krevans to Board of Directors (PR Newswire)
Oct-16-24 02:00AM	Essential Pharma Announces the Appointment of Dr Liz Holmes as Chief Medical Officer (GlobeNewswire)
Oct-13-24 04:59PM	GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now (Insider Monkey)
Sep-30-24 09:04PM	CRCM LP's Strategic Acquisition of GRAIL Inc Shares (GuruFocus.com)
Sep-03-24 11:37AM	Illumina Wins Court Fight With EU Over $7 Billion Grail Deal (Bloomberg) -6.02%
Aug-30-24 05:55PM	GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4) (PR Newswire)
Aug-29-24 04:16PM	Results of GRAIL's Galleri Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology (PR Newswire)
Aug-21-24 04:01PM	GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire) +5.35%
Aug-17-24 10:05PM	Illumina, Inc. (ILMN): Is This Cheap Robotic Stock a Good Buy Right Now? (Insider Monkey)
Aug-16-24 08:01PM	10 Cheap Robotics Stocks To Buy (Insider Monkey) +5.55%
Aug-14-24 08:07AM	Grail to shed 350 workers in restructuring (MedTech Dive)
Aug-13-24 04:01PM	GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update (PR Newswire)
Aug-08-24 08:05AM	Wheels Up Announces Gregory Summe to Join Board of Directors (PR Newswire)
Jul-31-24 04:05PM	GRAIL to Announce Second Quarter 2024 Financial Results (PR Newswire) +8.19%
Jul-24-24 08:55AM	Heres Why You Should Add Illumina (ILMN) to Your Portfolio (Insider Monkey)
Jul-19-24 06:53AM	Grail announces first patients enrolled in REACH cancer trial (Medical Device Network)
Jul-18-24 09:00AM	GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri Multi-Cancer Early Detection (MCED) Test in the Medicare Population (PR Newswire) -14.63%
Jul-17-24 06:30AM	3 Top Cancer Treatment Stocks to Buy Now (InvestorPlace)
Jul-15-24 12:31PM	3 Spinoff Stocks You Should Buy Now: July 2024 (InvestorPlace) +5.27%
03:01AM	GRAIL Advances the Galleri Registrational Clinical Trial Program (PR Newswire)
Jul-05-24 06:55AM	3 Biotech Stocks Turning DNA Dreams Into Dollars (InvestorPlace)
Jun-28-24 01:02AM	Gene-sequencing group Illumina sees $1.47 bn Q2 impairment charge linked to Grail (Investing.com)
Jun-27-24 05:26PM	Illumina to take $1.47 billion goodwill impairment charge related to Grail in Q2 (Reuters) -9.38%

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Ofman Joshua J.	President	May 02 '25	Sale	33.93	48,213	1,635,867	511,460	May 05 09:44 PM
Freidin Aaron	Chief Financial Officer	May 02 '25	Sale	33.93	41,150	1,396,220	294,020	May 05 08:46 PM
RAGUSA ROBERT P	Chief Executive Officer	May 02 '25	Sale	33.93	94,035	3,190,608	734,627	May 05 08:44 PM
Aaron Freidin	Officer	May 01 '25	Proposed Sale	36.81	42,138	1,551,100		Apr 29 09:06 PM
Robert Ragusa	Director	May 01 '25	Proposed Sale	36.81	96,207	3,541,380		Apr 29 08:29 PM
Joshua J. Ofman	Officer	May 01 '25	Proposed Sale	36.81	47,083	1,733,136		Apr 29 08:19 PM
RAGUSA ROBERT P	Chief Executive Officer	Mar 07 '25	Sale	31.21	7,625	237,976	828,662	Mar 12 04:07 PM
Ofman Joshua J.	President	Mar 07 '25	Sale	31.20	2,109	65,801	559,673	Mar 12 04:06 PM
Freidin Aaron	Chief Financial Officer	Mar 07 '25	Sale	31.20	1,816	56,659	335,170	Mar 12 04:04 PM
Robert Ragusa	Officer	Mar 05 '25	Proposed Sale	36.33	9,102	330,676		Mar 03 08:40 PM
Joshua J. Ofman	Officer	Mar 05 '25	Proposed Sale	36.33	2,897	105,248		Mar 03 08:02 PM
Aaron Freidin	Officer	Mar 05 '25	Proposed Sale	36.33	2,560	93,005		Mar 03 08:00 PM
Freidin Aaron	Chief Financial Officer	Nov 18 '24	Sale	14.02	30,452	426,937	268,277	Nov 19 04:06 PM
Aaron Freidin	Officer	Nov 18 '24	Proposed Sale	14.80	31,721	469,471		Nov 15 06:38 PM
RAGUSA ROBERT P	Chief Executive Officer	Oct 15 '24	Sale	14.02	123,454	1,730,825	612,661	Oct 17 06:32 PM
Robert Ragusa	Officer	Oct 14 '24	Proposed Sale	14.49	135,454	1,962,728		Oct 11 06:01 PM
DING CHUN R	10% Owner	Oct 03 '24	Buy	12.71	35,000	444,850	3,558,655	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 02 '24	Buy	13.37	20,000	267,400	3,523,655	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 09 '24	Buy	12.92	16,200	209,304	3,644,855	Oct 10 07:45 PM
DING CHUN R	10% Owner	Oct 01 '24	Buy	13.52	7,629	103,144	3,503,655	Oct 10 07:45 PM
Joshua J. Ofman	Officer	Aug 21 '24	Proposed Sale	16.25	74,084	1,203,650		Oct 07 08:38 PM
Aaron Freidin	Officer	Aug 21 '24	Proposed Sale	16.25	15,641	254,121		Oct 07 08:37 PM
Freidin Aaron	Chief Financial Officer	Aug 21 '24	Sale	16.25	15,641	254,121	173,429	Aug 22 04:02 PM
Ofman Joshua J.	President	Aug 21 '24	Sale	16.25	74,084	1,203,650	191,757	Aug 22 04:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

GRAL

GRAIL Inc

Upgrade your FINVIZ experience